Publication | Closed Access

Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Hematological MalignancyOncologyTransplantationMarrow TransplantationMedicineHematologyStem Cell TherapiesCell TransplantationAdult T-cell Leukemia-lymphomaStem CellsCell BiologyHealth Sciences